Decision Instrument · System Strategy & Reform Sequencing · Payer or Provider
Reform Sequencing Navigator
A 25-question structured assessment scoring your exposure and readiness across every converging Saudi healthcare reform: structure, payment, capital, coverage, intelligence, and foundations. It produces a ranked sequencing priority list and directs you to the specific diagnostics to run first.
5 domains
25 questions
Approximately 15 minutes
Payer or provider perspective
Self-assessment version. Available as a facilitated Full Diagnostic as the Strategic Bundle: three facilitated Full Diagnostics chosen by this sequencing, a decision sequencing workshop, and cross-diagnostic risk mapping.
Your perspective frames the results narrative. Every organisation answers the same exposure and readiness questions.
Section 1 of 50% complete
Section 1 of 5
System Structure & Payment
Exposure and readiness across the structural destination (clusters, accountable care, capitation) and the payment reforms feeding it (AR-DRG, value-based contracts).
Maps: Structure & Payment layers
Question 1 · Exposure
How materially does the cluster and risk-adjusted capitation transition affect your revenue model and market position?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 2 · Readiness
How prepared is your organisation to operate with population accountability under capitation?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Question 3 · Exposure
How materially does AR-DRG episode payment affect your reimbursement economics?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 4 · Readiness
How prepared are your coding, costing, and documentation capabilities for DRG operation?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Question 5 · Exposure
How material are value-based and outcome-linked contracts to your growth or purchasing strategy?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 6 · Readiness
How prepared are you to price, measure, and govern value-based contracts beyond year three?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Section 2 of 5
Capital & Coverage
The financial rulebook: the risk-based capital regime, and the coverage frontier decisions such as GLP-1 arriving with no local precedent.
Maps: Capital & Coverage layer
Question 7 · Exposure
How materially does the risk-based capital framework affect your capital, pricing, or partner solvency?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 8 · Readiness
How prepared are your capital modelling, risk evidence, and governance for the RBC regime?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Question 9 · Exposure
How materially does GLP-1 demand and coverage affect your pharmacy spend or service model?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 10 · Readiness
How prepared is your coverage position: criteria, prior authorisation, budget model, stopping rules?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Section 3 of 5
Intelligence & Cost Integrity
The analytical capabilities the reforms assume: NPHIES maturity, FWA governance, and pharmacy benefit management.
Maps: Intelligence layer
Question 11 · Exposure
How material is NPHIES data to your competitive intelligence and operations?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 12 · Readiness
How advanced is your NPHIES maturity beyond compliance, towards intelligence use?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Question 13 · Exposure
How material is claims fraud, waste, and abuse exposure to your financial results?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 14 · Readiness
How prepared is your FWA governance, with detection calibrated for the right failure mode?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Question 15 · Exposure
How material is pharmacy spend growth to your medical cost trend?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 16 · Readiness
How prepared is your PBM capability: formulary governance, substitution, utilisation management?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Section 4 of 5
Care Model & Population
Population health capability under the five-condition agenda, and homecare against the capacity ceiling.
Maps: Care model layer
Question 17 · Exposure
How material is population health performance to your strategy under the five-condition agenda?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 18 · Readiness
How prepared are you to stratify, intervene, and measure outcomes at population level?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Question 19 · Exposure
How material is homecare to your capacity, discharge, or coverage strategy against the bed shortfall?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 20 · Readiness
How prepared are you to launch or scale homecare with clinical accountability and reimbursement clarity?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Section 5 of 5
Foundations & Integration
The layer everything depends on: PDPL data governance, AI governance, and whether the combined portfolio is governed as one programme.
Maps: Foundations layer
Question 21 · Exposure
How material is sensitive health data processing to your operations and analytics ambition?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 22 · Readiness
How prepared is your PDPL foundation: lawful basis, records of processing, transfers, breach response?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Question 23 · Exposure
How material is AI deployment to your clinical or operational roadmap?
High exposure - 3Central to our economics or mandate within the next 24 months.
Moderate exposure - 2Material but not decisive; affects parts of the organisation.
Limited exposure - 1Peripheral to our operating model in the planning horizon.
Question 24 · Readiness
How prepared is your AI governance: accountability, validation, drift monitoring, human oversight?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Question 25 · Readiness
Is the combined reform programme governed as one portfolio, with a single owner, a dependency map, and a deliberate sequence?
Strong - 3 pointsAssessed, resourced, and governed, with a plan in execution.
Partial - 2 pointsRecognised with early work, but gaps in plan or capability.
Weak - 0 pointsNot yet assessed or addressed.
Reform Sequencing Navigator - Results
Your Sequencing Priorities
0
/ 108
Calculating...
Processing...
Ranked Sequencing Priorities
Priority reflects where high exposure and low readiness coincide (exposure × readiness gap, scored 0 to 9). Your top priorities are where change capacity should go first.
Indicative Findings
Calculating...
This navigator shows the sequence. The Strategic Bundle executes it.
The facilitated Strategic Bundle takes your top three priorities into three Full Diagnostics, a decision sequencing workshop, cross-diagnostic risk mapping, and a 90-day follow-up: the full programme view this navigator indicates.
The Reform Convergence: Why Sequencing Is Now the Strategic Decision in Saudi Healthcare
The analytical context behind this navigator: why the reforms are one structural shift, the dependency map beneath them, and why change capacity is the binding constraint.